Skip to main content
Erschienen in:

09.01.2024

Outcomes of an expedited same-day discharge protocol following cardiac implantable electronic device (CIED) implantation

verfasst von: Satish Misra, Kamala Swayampakala, Aparna Rajwani, Elizabeth Davenport, John Fedor, Sherry Saxonhouse, John Holshouser, Neel Patel, Joseph Thompson, Elijah Beaty, Manish Jain, Brian Powell, Rohit Mehta

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

With increasing constraints on healthcare resources, greater attention is being focused on improved resource utilization. Prior studies have demonstrated safety of same-day discharge following CIED implantation but are limited by vague protocols with long observation periods. In this study, we evaluate the safety of an expedited 2 hour same-day discharge protocol following CIED implantation.

Methods

Patients undergoing CIED implantation at three centers between 2015 and 2021 were included. Procedural, demographic, and adverse event data were abstracted from the electronic health record. Patients were divided into same-day discharge (SDD) and delayed discharge (DD) cohorts. The primary outcome was complications including lead malfunction requiring revision, pneumothorax, hemothorax, lead dislodgement, lead perforation with tamponade, and mortality within 30 days of procedure. Outcomes were compared between the two cohorts using the χ2 test.

Results

A total of 4543 CIED implantation procedures were included with 1557 patients (34%) in the SDD cohort. SDD patients were comparatively younger, were more likely to be male, and had fewer comorbidities than DD patients. Among SDD patients, the mean time to post-operative chest X-ray was 2.6 h. SDD had lower rates of complications (1.3% vs 2.1%, p = 0.0487) and acute care utilization post-discharge (9.6% vs 14.0%, p < 0.0001). There was no difference in the 90-day infection rate between the cohorts.

Conclusions

An expedited 2 hour same-day discharge protocol is safe and effective with low rates of complications, infection, and post-operative acute care utilization.
Literatur
1.
Zurück zum Zitat Scott M, et al. Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic. Heart Rhythm O2. 2022;4(3):193–9.PubMedPubMedCentral Scott M, et al. Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic. Heart Rhythm O2. 2022;4(3):193–9.PubMedPubMedCentral
2.
Zurück zum Zitat Tsao CW, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639.CrossRefPubMed Tsao CW, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153–639.CrossRefPubMed
3.
Zurück zum Zitat Trongtorsak A, et al. Same-day discharge after implantation of cardiac implantable electronic devices: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021;44(11):1925–33.CrossRefPubMed Trongtorsak A, et al. Same-day discharge after implantation of cardiac implantable electronic devices: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2021;44(11):1925–33.CrossRefPubMed
4.
Zurück zum Zitat Hess PL, et al. Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention. J Am Coll Cardiol. 2015;65(9):955–7.CrossRefPubMed Hess PL, et al. Same-day discharge and risks of mortality and readmission after elective ICD placement for primary prevention. J Am Coll Cardiol. 2015;65(9):955–7.CrossRefPubMed
5.
Zurück zum Zitat Wadhwani L, et al. Time to diagnosis of acute complications after cardiovascular implantable electronic device insertion and optimal timing of discharge within the first 24 hours. Heart Rhythm. 2021;18(12):2110–4.CrossRefPubMed Wadhwani L, et al. Time to diagnosis of acute complications after cardiovascular implantable electronic device insertion and optimal timing of discharge within the first 24 hours. Heart Rhythm. 2021;18(12):2110–4.CrossRefPubMed
6.
Zurück zum Zitat Darda S, et al. Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention. Pacing Clin Electrophysiol. 2013;36(7):885–91.CrossRefPubMed Darda S, et al. Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention. Pacing Clin Electrophysiol. 2013;36(7):885–91.CrossRefPubMed
7.
Zurück zum Zitat Osman F, et al. Safety and cost-effectiveness of same day permanent pacemaker implantation. Am J Cardiol. 2010;106(3):383–5.CrossRefPubMed Osman F, et al. Safety and cost-effectiveness of same day permanent pacemaker implantation. Am J Cardiol. 2010;106(3):383–5.CrossRefPubMed
8.
Zurück zum Zitat Heyde GS, et al. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation. 2007;115(17):2299–306.CrossRefPubMed Heyde GS, et al. Randomized trial comparing same-day discharge with overnight hospital stay after percutaneous coronary intervention: results of the Elective PCI in Outpatient Study (EPOS). Circulation. 2007;115(17):2299–306.CrossRefPubMed
9.
Zurück zum Zitat Shroff A, et al. Same-day discharge after percutaneous coronary intervention: current perspectives and strategies for implementation. JAMA Cardiol. 2016;1(2):216–23.CrossRefPubMed Shroff A, et al. Same-day discharge after percutaneous coronary intervention: current perspectives and strategies for implementation. JAMA Cardiol. 2016;1(2):216–23.CrossRefPubMed
10.
Zurück zum Zitat Budano C, et al. Same-day CIED implantation and discharge: is it possible? The E-MOTION trial (Early MObilization after pacemaker implantaTION). Int J Cardiol. 2019;288:82–6.CrossRefPubMed Budano C, et al. Same-day CIED implantation and discharge: is it possible? The E-MOTION trial (Early MObilization after pacemaker implantaTION). Int J Cardiol. 2019;288:82–6.CrossRefPubMed
11.
Zurück zum Zitat Choudhuri I, et al. Feasibility of early discharge after implantable cardioverter-defibrillator procedures. J Cardiovasc Electrophysiol. 2012;23(10):1123–9.CrossRefPubMed Choudhuri I, et al. Feasibility of early discharge after implantable cardioverter-defibrillator procedures. J Cardiovasc Electrophysiol. 2012;23(10):1123–9.CrossRefPubMed
12.
Zurück zum Zitat Peplow J, et al. Day-case device implantation-a prospective single-center experience including patient satisfaction data. Pacing Clin Electrophysiol. 2018;41(5):546–52.CrossRefPubMed Peplow J, et al. Day-case device implantation-a prospective single-center experience including patient satisfaction data. Pacing Clin Electrophysiol. 2018;41(5):546–52.CrossRefPubMed
13.
Zurück zum Zitat Datino T, et al. Safety of outpatient implantation of the implantable cardioverter-defibrillator. Rev Esp Cardiol (Engl Ed). 2015;68(7):579–84.CrossRefPubMed Datino T, et al. Safety of outpatient implantation of the implantable cardioverter-defibrillator. Rev Esp Cardiol (Engl Ed). 2015;68(7):579–84.CrossRefPubMed
14.
Zurück zum Zitat Ohlow MA, et al. Very early discharge after cardiac implantable electronic device implantations: is this the future? J Interv Card Electrophysiol. 2021;60(2):231–7.CrossRefPubMed Ohlow MA, et al. Very early discharge after cardiac implantable electronic device implantations: is this the future? J Interv Card Electrophysiol. 2021;60(2):231–7.CrossRefPubMed
15.
Zurück zum Zitat Nelson T, et al. Evaluation of a new same-day discharge protocol for simple and complex pacing procedures. Br J Cardiol. 2016;23:114–8. Nelson T, et al. Evaluation of a new same-day discharge protocol for simple and complex pacing procedures. Br J Cardiol. 2016;23:114–8.
16.
Zurück zum Zitat Archontakis S, Oikonomou E, Sideris K, Laina A, Tirovola D, Paraskevopoulou D, Kostakis P, Doundoulakis I, Arsenos P, Ntalakouras I, Charitakis E, Gatzoulis K, Tsioufis K, Sideris S. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience. J Interv Card Electrophysiol. 2023;66(2):471–81.CrossRefPubMed Archontakis S, Oikonomou E, Sideris K, Laina A, Tirovola D, Paraskevopoulou D, Kostakis P, Doundoulakis I, Arsenos P, Ntalakouras I, Charitakis E, Gatzoulis K, Tsioufis K, Sideris S. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience. J Interv Card Electrophysiol. 2023;66(2):471–81.CrossRefPubMed
Metadaten
Titel
Outcomes of an expedited same-day discharge protocol following cardiac implantable electronic device (CIED) implantation
verfasst von
Satish Misra
Kamala Swayampakala
Aparna Rajwani
Elizabeth Davenport
John Fedor
Sherry Saxonhouse
John Holshouser
Neel Patel
Joseph Thompson
Elijah Beaty
Manish Jain
Brian Powell
Rohit Mehta
Publikationsdatum
09.01.2024
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 5/2024
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-024-01734-w

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

Mehr Cholesterin im Essen = höheres Herzinfarktrisiko

Je mehr Cholesterin man täglich über die Nahrung zu sich nimmt, desto höher ist offenbar das Herzinfarktrisiko – das legt eine Studie mit US-Veteranen zumindest für Männer nahe.

Antikoagulation bei Vorhofflimmern: Sind DOAK noch zu toppen?

Gegen Thromboembolien so wirksam wie ein DOAK, bei zugleich geringerem Blutungsrisiko – werden Faktor-XI-Hemmer als neue Antikoagulanzien dieser Erwartung gerecht? Eine aktuell publizierte Vergleichsstudie gibt darüber Aufschluss.

"Stammzell-Pflaster" gegen geschwächte Herzen: Hoffnung oder Hype?

Eine Nature-Publikation zur Behandlung der Herzinsuffizienz mit von Stammzellen abgeleiteten Herzzellen sorgt in Publikumsmedien für Wirbel. Deren Erkenntnisse sind in der Tat spektakulär – und gleichzeitig vorläufig und ernüchternd. 

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.